Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 1, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Francois Brisebois Reiterated (ACHV) at Buy and Held Target at $18 on, Apr 1st, 2024
Francois Brisebois of Oppenheimer, Reiterated "Achieve Life Sciences, Inc." (ACHV) at Buy and Held Target at $18 on, Apr 1st, 2024.
Francois has made no other calls on ACHV in the last 4 months.
There is 1 other peer that has a rating on ACHV. Out of the 1 peers that are also analyzing ACHV, 0 agree with Francois's Rating of Hold.
This is the rating of the analyst that currently disagrees with Francois
- Thomas Flaten of "Lake Street" Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, March 5th, 2024
